Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review
- Author(s)
- Dato, PE; De La Cerda, J; Armstrong, AJ; Azad, AA; Conduit, C; Haas, GP; Kernen, K; Klaassen, ZW; Patel, R; Saad, F; Shore, ND; Freedland, SJ; Karsh, LI;
- Journal Title
- Future Oncology
- Abstract
- GOAL: To present data from published clinical trials of treatment of patients with prostate cancer with enzalutamide described in plain language and in a dashboard format. RATIONALE: Treatments that are clinically active in advanced prostate cancer may benefit patients as they are treated earlier in the disease. OBJECTIVE: To show how overall survival improves as patients are treated with enzalutamide earlier in the disease.
- Publisher
- Taylor & Frances
- Keywords
- Plain language review; advanced prostate cancer; enzalutamide; metastasis-free survival; overall survival; patient-reported outcomes; prostate cancer; prostate neoplasms
- Research Division(s)
- Personalised Oncology
- PubMed ID
- 40583299
- Publisher's Version
- https://doi.org/10.1080/14796694.2025.2475730
- Open Access at Publisher's Site
https://doi.org/10.1080/14796694.2025.2475730- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-07-28 08:47:50
Last Modified: 2025-07-28 08:48:02